Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome
Abstract Glut1 deficiency syndrome is caused by SLC2A1 mutations on chromosome 1p34.2 that impairs glucose transport across the blood–brain barrier resulting in hypoglycorrhachia and decreased fuel for brain metabolism. Neuroglycopenia causes a drug‐resistant metabolic epilepsy due to energy deficie...
Saved in:
Main Authors: | Santhi N. Logel, Ellen L. Connor, David A. Hsu, Rachel J. Fenske, Neil J. Paloian, Darryl C. De Vivo |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/1006b62dddf24bd2aac90a7b32bca90a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein
by: Maoxue Tang, et al.
Published: (2017) -
Peritoneal expression of SGLT-2, GLUT1 and GLUT3 in peritoneal dialysis patients
by: Severin Schricker, et al.
Published: (2021) -
Decreased basal chloride secretion and altered cystic fibrosis transmembrane conductance regulatory protein, Villin, GLUT5 protein expression in jejunum from leptin-deficient mice
by: Leung L, et al.
Published: (2014) -
Loss of sugar detection by GLUT2 affects glucose homeostasis in mice.
by: Emilie Stolarczyk, et al.
Published: (2007) -
GLUT1 overexpression enhances glucose metabolism and promotes neonatal heart regeneration
by: Viviana M. Fajardo, et al.
Published: (2021)